Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 23 Issue 2
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2005  >  (2): 103-104

ZHENG Ji-hai, WANG Jin-cai, LU Guang-zhou. Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis[J]. Journal of Pharmaceutical Practice and Service, 2005, (2): 103-104.
Citation: ZHENG Ji-hai, WANG Jin-cai, LU Guang-zhou. Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis[J]. Journal of Pharmaceutical Practice and Service, 2005, (2): 103-104.
shu

Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis

  • Received Date: 2004-11-23
  • Objective To evaluate the economic effectiveness of domestic ulinastatin and sandostain in the treatment of acute pancreatitis. Methods 41 cases with acute pancreatitis were divided into 2 groups according to the therapeutic drug: the ulinastatin group and the sandostain group. The two groups were compared by cost-minimization analysis of pharmacoeconomics. Results There is no significant difference in clinical therapeutic effect between two groups, but the cost of the sandostain group is much higher than the ulinastatin group. Conclusion The cost of domestic ulinastatin is minimization.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2590) PDF downloads(383) Cited by()

Related
Proportional views

Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis

  • Received Date: 2004-11-23

Abstract: Objective To evaluate the economic effectiveness of domestic ulinastatin and sandostain in the treatment of acute pancreatitis. Methods 41 cases with acute pancreatitis were divided into 2 groups according to the therapeutic drug: the ulinastatin group and the sandostain group. The two groups were compared by cost-minimization analysis of pharmacoeconomics. Results There is no significant difference in clinical therapeutic effect between two groups, but the cost of the sandostain group is much higher than the ulinastatin group. Conclusion The cost of domestic ulinastatin is minimization.

ZHENG Ji-hai, WANG Jin-cai, LU Guang-zhou. Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis[J]. Journal of Pharmaceutical Practice and Service, 2005, (2): 103-104.
Citation: ZHENG Ji-hai, WANG Jin-cai, LU Guang-zhou. Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis[J]. Journal of Pharmaceutical Practice and Service, 2005, (2): 103-104.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return